ADIL

ADIAL PHARMACEUTICALS, INC.

ADIAL PHARMACEUTICALS, INC. (ADIL) has 4 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 16, 2026.

The most active filer is 10% Owner Coastlands Capital LP with 5 filings. Insiders have net bought $106K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Cary John Claiborne
  • Employees:5
  • HQ:Charlottesville, VA, US
  • IPO:2018-07-27

Insider Buying

$106K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$5.7M

latest known value

Source
Purchase$5KJul 16SEC ↗
Purchase$3KJul 16SEC ↗
Purchase$28KJul 13SEC ↗
Purchase$5KJul 13SEC ↗
Purchase$65KJul 1SEC ↗

Related companies

ADIAL PHARMACEUTICALS, INC. is in the Healthcare sector.